Jian Cui Selected Research

sangu

4/2012	Effect of Sangu Decoction () on metastatic bone destruction in rats with mammary cancer.
1/2012	Effects of sangu decoction on osteoclast activity in a rat model of breast cancer bone metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Cui Research Topics

Disease

64	Neoplasms (Cancer) 01/2024 - 04/2003
16	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2012
13	Inflammation (Inflammations) 01/2024 - 02/2009
13	Lung Neoplasms (Lung Cancer) 12/2023 - 04/2013
12	Pain (Aches) 04/2024 - 01/2011
10	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2012
9	Neuralgia (Stump Neuralgia) 01/2023 - 04/2011
8	Atherosclerosis 04/2024 - 11/2010
8	Hypoxia (Hypoxemia) 01/2023 - 09/2009
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2017
8	Carcinogenesis 07/2022 - 04/2013
6	Multiple Myeloma 04/2024 - 01/2018
6	Hyperalgesia 11/2022 - 01/2012
5	Hypertension (High Blood Pressure) 12/2024 - 02/2005
5	Infections 10/2023 - 01/2016
5	Adenocarcinoma of Lung 05/2022 - 08/2011
5	Wounds and Injuries (Trauma) 04/2022 - 01/2011
5	Rectal Neoplasms (Rectal Cancer) 12/2020 - 06/2015
4	Colitis 04/2024 - 06/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2020
4	Chromosome Aberrations (Chromosome Abnormalities) 12/2023 - 08/2023
4	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2012
4	Ischemia 12/2022 - 09/2007
4	Fibrosis (Cirrhosis) 01/2021 - 01/2019
4	Intervertebral Disc Displacement (Herniated Disc) 05/2017 - 03/2016
3	Ulcerative Colitis 04/2024 - 11/2019
3	Genomic Instability 12/2023 - 01/2022
3	Type 2 Diabetes Mellitus (MODY) 12/2023 - 02/2005
3	Body Weight (Weight, Body) 01/2023 - 06/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 07/2018
3	Colonic Neoplasms (Colon Cancer) 11/2020 - 01/2011
3	Hepatitis B 01/2020 - 03/2015
3	Prostatic Neoplasms (Prostate Cancer) 12/2019 - 01/2015
3	Glioma (Gliomas) 10/2018 - 10/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 03/2003
3	Flatulence 01/2017 - 02/2014
3	Obesity 01/2016 - 11/2010
3	Hepatopulmonary Syndrome 11/2015 - 01/2014
3	Vascular Remodeling 08/2015 - 10/2005
3	Carcinoma (Carcinomatosis) 01/2015 - 07/2011
3	Esophageal Neoplasms (Esophageal Cancer) 04/2014 - 03/2013
2	Disease Progression 04/2024 - 12/2023
2	Dyspnea (Shortness of Breath) 02/2024 - 01/2023
2	Asthma (Bronchial Asthma) 01/2024 - 02/2019
2	Hyperplasia 01/2024 - 01/2022
2	Residual Neoplasm 01/2024 - 01/2024

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2003
11	CytokinesIBA 01/2023 - 02/2009
11	Messenger RNA (mRNA)IBA 01/2022 - 10/2006
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 05/2011
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2014
6	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2015
6	LipidsIBA 01/2023 - 11/2010
6	kushenIBA 01/2020 - 10/2016
5	Particulate MatterIBA 10/2022 - 01/2019
5	Circular RNAIBA 10/2022 - 01/2018
5	Small Interfering RNA (siRNA)IBA 03/2022 - 08/2011
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2012
5	Therapeutic UsesIBA 08/2021 - 04/2018
4	CollagenIBA 01/2024 - 02/2011
4	AntigensIBA 12/2023 - 05/2013
4	Receptor for Advanced Glycation End ProductsIBA 01/2023 - 01/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2017
3	Dextran SulfateIBA 04/2024 - 11/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2016
3	ErbB Receptors (EGF Receptor)IBA 12/2023 - 05/2013
3	InflammasomesIBA 10/2023 - 01/2021
3	urinastatin (MR 20)IBA 01/2023 - 09/2017
3	Apolipoproteins E (ApoE)IBA 01/2023 - 06/2013
3	Epidermal Growth Factor (EGF)IBA 01/2023 - 08/2011
3	MetalsIBA 01/2023 - 12/2009
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 08/2011
3	Estrogen ReceptorsIBA 01/2023 - 01/2018
3	Dexmedetomidine FDA Link 11/2022 - 09/2015
3	Long Noncoding RNAIBA 01/2022 - 10/2016
3	AntioxidantsIBA 01/2022 - 09/2009
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 06/2011
3	C-Reactive ProteinIBA 01/2021 - 02/2014
3	Caspase 3 (Caspase-3)IBA 11/2020 - 04/2015
3	VaccinesIBA 01/2020 - 06/2015
3	ChemokinesIBA 01/2019 - 11/2010
3	Polysaccharides (Glycans)IBA 01/2018 - 04/2003
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 09/2017 - 04/2011
3	Protein Isoforms (Isoforms)IBA 12/2009 - 03/2005
2	CreatinineIBA 12/2024 - 01/2023
2	niraparibIBA 04/2024 - 03/2023
2	Adenosine Monophosphate (AMP)IBA 04/2024 - 08/2023
2	Monoclonal AntibodiesIBA 04/2024 - 01/2021
2	OvalbuminIBA 01/2024 - 02/2019
2	Hormones (Hormone)IBA 01/2024 - 11/2010
2	Hematoxylin (Haematoxylon)IBA 12/2023 - 04/2020

Therapy/Procedure

22	Therapeutics 01/2024 - 06/2015
7	Drug Therapy (Chemotherapy) 11/2023 - 04/2003
6	Length of Stay 01/2017 - 01/2011
5	Immunotherapy 04/2024 - 01/2022
5	Neoadjuvant Therapy 12/2020 - 06/2015
4	Anesthesia 01/2023 - 06/2015
4	Ligation 09/2017 - 01/2012
3	Operative Time 01/2018 - 01/2011